Migraine trials in Hungary

3 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

  Where

  Budapest, Budapest XIV

  Age

  12 years to 17 years

  People

  420 worldwide

  Run by

  AbbVie

  See details and how to joinNCT06810505 · EU 2024-513836-28-00
• Phase 3Taking people
  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  Where

  Budapest, Budapest II, Budapest III, Budapest VIII, Budapest Xiv

  Age

  6 years to 17 years

  People

  450 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05711394 · EU 2022-501100-94-00
• Phase 3Enrolling by invitation
  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  Where

  Budapest, Budapest II, Budapest III, Budapest VIII, Budapest Xiv

  Age

  6 years to 17 years

  People

  650 worldwide

  Run by

  AbbVie

  See details and how to joinNCT05707949 · EU 2022-501099-24-00